Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report

Medicine and Dentistry

• Bone Metastasis 100%
• Denosumab 83%
• Patient 83%
• Diseases 33%
• Serum 33%
• Breast Cancer 33%
• Hormone Therapy 33%
• Kidney Function 33%
• Parathyroid Hormone 33%
• Isotopes of Calcium 16%
• Surgery 16%
• Analgesia 16%
• Solid Malignant Neoplasm 16%
• Phosphorus 16%
• Chronic Kidney Disease 16%
• Adverse Event 16%
• Albumin 16%
• Cancer Diagnosis 16%
• Hormone Determination 16%
• Hypocalcaemia 16%
• Pain 16%
• Severe Renal Impairment 16%
• Pamidronic Acid 16%
• Physician 16%
• Childhood 16%
• Bone 16%
• Inpatient 16%
• Woman 16%
• Adjustment 16%
• Patient with Cancer 16%
• Hip 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Bone Metastasis 100%
• Denosumab 83%
• Dialysis 83%
• Case Report 66%
• Diseases 33%
• Breast Cancer 33%
• Parathyroid Hormone 33%
• Vitamin D Analogue 33%
• Adverse Event 16%
• Albumin 16%
• Chronic Kidney Failure 16%
• Tolerability 16%
• Phosphorus 16%
• Solid Malignant Neoplasm 16%
• Severe Renal Impairment 16%
• Pain 16%
• Hypocalcemia 16%
• Calcium 16%
• Pamidronic Acid 16%